First Header Logo Second Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Steven Feldman and Lindsay Strowd.
Steven Feldman
Connection Strength
4.225
Lindsay Strowd
  1. Strowd LC, Feldman SR. Dupilumab for atopic dermatitis. Lancet. 2017 06 10; 389(10086):2265-2266.
    View in: PubMed
    Score: 0.589
  2. Strowd LC, Yentzer BA, Fleischer AB, Feldman SR. Increasing use of more potent treatments for psoriasis. J Am Acad Dermatol. 2009 Mar; 60(3):478-81.
    View in: PubMed
    Score: 0.329
  3. Tier HL, Balogh EA, Bashyam AM, Fleischer AB, Spergel JM, Masicampo EJ, Kammrath LK, Strowd LC, Feldman SR. Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review. Dermatol Ther (Heidelb). 2021 Apr; 11(2):415-431.
    View in: PubMed
    Score: 0.192
  4. Newsom M, Hrin ML, Hamid RN, Strowd LC, Ahn C, Jorizzo JL, Feldman SR. Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab. Dermatol Online J. 2021 Jan 15; 27(1).
    View in: PubMed
    Score: 0.190
  5. Gao JC, Emmerich VK, Feldman S, Strowd LC. Evaluating calcipotriene 0.005% foam for the treatment of plaque psoriasis of the scalp and body in patients aged 12 years and older. Expert Opin Pharmacother. 2021 Apr; 22(5):543-547.
    View in: PubMed
    Score: 0.189
  6. Ghamrawi R, Bell KA, Balogh EA, Strowd LC, Feldman SR. Current and emerging biologics for the treatment of pediatric atopic dermatitis. Expert Opin Biol Ther. 2020 12; 20(12):1435-1445.
    View in: PubMed
    Score: 0.188
  7. Singh R, Heron CE, Ghamrawi RI, Strowd LC, Feldman SR. Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis. Immunotargets Ther. 2020; 9:255-272.
    View in: PubMed
    Score: 0.188
  8. Newsom M, Bashyam AM, Balogh EA, Feldman SR, Strowd LC. New and Emerging Systemic Treatments for Atopic Dermatitis. Drugs. 2020 Jul; 80(11):1041-1052.
    View in: PubMed
    Score: 0.183
  9. Cline A, Berg A, Bartos GJ, Strowd LC, Feldman SR. Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis-A Review. J Clin Aesthet Dermatol. 2020 Jun; 13(6 Suppl):33-38.
    View in: PubMed
    Score: 0.182
  10. Mendes JT, Balogh EA, Strowd LC, Feldman SR. An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis. Expert Opin Pharmacother. 2020 Jun; 21(9):1027-1033.
    View in: PubMed
    Score: 0.180
  11. Howell AN, Ghamrawi RI, Strowd LC, Feldman SR. Pharmacological management of atopic dermatitis in the elderly. Expert Opin Pharmacother. 2020 May; 21(7):761-771.
    View in: PubMed
    Score: 0.179
  12. Cline A, Bartos GJ, Strowd LC, Feldman SR. Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis. Children (Basel). 2019 Sep 11; 6(9).
    View in: PubMed
    Score: 0.173
  13. Ramachandran V, Cline A, Feldman SR, Strowd LC. Evaluating crisaborole as a treatment option for atopic dermatitis. Expert Opin Pharmacother. 2019 Jun; 20(9):1057-1063.
    View in: PubMed
    Score: 0.169
  14. Feldman SR, Cox LS, Strowd LC, Gerber RA, Faulkner S, Sierka D, Smith TW, Cappelleri JC, Levenberg ME. The Challenge of Managing Atopic Dermatitis in the United States. Am Health Drug Benefits. 2019 Apr; 12(2):83-93.
    View in: PubMed
    Score: 0.168
  15. Glines KR, Stiff KM, Freeze M, Cline A, Strowd LC, Feldman SR. An update on the topical and oral therapy options for treating pediatric atopic dermatitis. Expert Opin Pharmacother. 2019 04; 20(5):621-629.
    View in: PubMed
    Score: 0.165
  16. Guda A, Feldman SR, Strowd L. Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon. Expert Opin Investig Drugs. 2018 11; 27(11):931-939.
    View in: PubMed
    Score: 0.163
  17. Seger EW, Wechter T, Strowd L, Feldman SR. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2019 Feb; 80(2):411-416.e4.
    View in: PubMed
    Score: 0.163
  18. Edwards T, Patel NU, Blake A, Prabakaran S, Reimer D, Feldman SR, Strowd LC. Insights into future therapeutics for atopic dermatitis. Expert Opin Pharmacother. 2018 02; 19(3):265-278.
    View in: PubMed
    Score: 0.155
  19. Shukla S, Feldman SR, Strowd LC. A safety review of the medications used to treat atopic dermatitis. Expert Opin Drug Saf. 2018 02; 17(2):179-183.
    View in: PubMed
    Score: 0.153
  20. Gerard AJ, Feldman SR, Strowd L. Quality of Life of Patients With Pyoderma Gangrenosum and Hidradenitis Suppurativa. J Cutan Med Surg. 2015 Jul-Aug; 19(4):391-6.
    View in: PubMed
    Score: 0.127
  21. Al-Dabagh A, Milliron BJ, Strowd L, Feldman SR. A disease of the present: scurvy in "well-nourished" patients. J Am Acad Dermatol. 2013 Nov; 69(5):e246-e247.
    View in: PubMed
    Score: 0.116
  22. Adler-Neal AL, Cline A, Frantz T, Strowd L, Feldman SR, Taylor S. Complementary and Integrative Therapies for Childhood Atopic Dermatitis. Children (Basel). 2019 Oct 30; 6(11).
    View in: PubMed
    Score: 0.044
  23. Martin E, Huang WW, Strowd LC, Hinkel VS, Feldman SR, Williford PM. Public Perception of Ethical Issues in Dermatology: Evidenced by New York Times Commenters. Dermatol Surg. 2018 12; 44(12):1571-1577.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.